the nature portfolio aims to enhance the reproducibility of published research by promoting consistency and transparency in reporting. this reporting summary outlines key requirements for statistical analysis, software and code availability, data accessibility, and ethical considerations. for statistical analyses, the following must be included: exact sample sizes, whether measurements were taken from distinct samples, the statistical tests used (one- or two-sided), descriptions of covariates, assumptions, and corrections, and detailed statistical parameters including effect sizes and confidence intervals. for null hypothesis testing, the test statistic, confidence intervals, effect sizes, degrees of freedom, and p-values must be reported. for bayesian analysis, information on priors and mcmc settings is required. for hierarchical and complex designs, appropriate test levels and full reporting of outcomes are necessary. effect sizes, such as cohen's d or pearson's r, must be estimated and indicated. software and code used in the study include omnic (ver. 7.4), suns (ver. fy-2000), origina pro (ver. 10.0), and 2d shige (ver. 1.3). for manuscripts using custom algorithms or software, the code must be made available to editors and reviewers, ideally deposited in a community repository like github. data availability is required for all manuscripts, with a statement providing accession codes, unique identifiers, or web links for publicly available datasets, and any restrictions on data access. all data supporting the findings are available within the article and supplementary information or from the corresponding authors upon request. research involving human participants, their data, or biological material must include full information on the approval of the study protocol. the study design must disclose relevant details, even if negative. specific materials, systems, and methods used in the study must be indicated, with relevant items listed. eukaryotic cell lines and plant-related research are also covered in the reporting guidelines.the nature portfolio aims to enhance the reproducibility of published research by promoting consistency and transparency in reporting. this reporting summary outlines key requirements for statistical analysis, software and code availability, data accessibility, and ethical considerations. for statistical analyses, the following must be included: exact sample sizes, whether measurements were taken from distinct samples, the statistical tests used (one- or two-sided), descriptions of covariates, assumptions, and corrections, and detailed statistical parameters including effect sizes and confidence intervals. for null hypothesis testing, the test statistic, confidence intervals, effect sizes, degrees of freedom, and p-values must be reported. for bayesian analysis, information on priors and mcmc settings is required. for hierarchical and complex designs, appropriate test levels and full reporting of outcomes are necessary. effect sizes, such as cohen's d or pearson's r, must be estimated and indicated. software and code used in the study include omnic (ver. 7.4), suns (ver. fy-2000), origina pro (ver. 10.0), and 2d shige (ver. 1.3). for manuscripts using custom algorithms or software, the code must be made available to editors and reviewers, ideally deposited in a community repository like github. data availability is required for all manuscripts, with a statement providing accession codes, unique identifiers, or web links for publicly available datasets, and any restrictions on data access. all data supporting the findings are available within the article and supplementary information or from the corresponding authors upon request. research involving human participants, their data, or biological material must include full information on the approval of the study protocol. the study design must disclose relevant details, even if negative. specific materials, systems, and methods used in the study must be indicated, with relevant items listed. eukaryotic cell lines and plant-related research are also covered in the reporting guidelines.